# Dabrafenib Mesilate Capsules 75mg (タフィンラーカプセル７５ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291046M2027). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291046M2027
- **Product name (Japanese):** タフィンラーカプセル７５ｍｇ
- **English title:** Dabrafenib Mesilate Capsules 75mg
- **Active ingredient:** ダブラフェニブメシル酸塩
- **Active ingredient (INN):** Dabrafenib Mesilate
- **Strength / unit:** ７５ｍｇ１カプセル
- **Route:** Oral (内用薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Novartis Pharma (ノバルティス ファーマ)
- **NHI price (reference only):** JPY 7903.2 per ７５ｍｇ１カプセル
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291046M2027
- **JSON:** https://www.nifujipharma.com/api/drugs/4291046M2027

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Dabrafenib%20Mesilate%20Capsules%2075mg%20(%E3%82%BF%E3%83%95%E3%82%A3%E3%83%B3%E3%83%A9%E3%83%BC%E3%82%AB%E3%83%97%E3%82%BB%E3%83%AB%EF%BC%97%EF%BC%95%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291046M2027#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Dabrafenib Mesilate

- [Dabrafenib Mesilate Capsules 50mg (タフィンラーカプセル５０ｍｇ)](https://www.nifujipharma.com/drugs/4291046M1020) — ５０ｍｇ１カプセル, Novartis Pharma
- [Dabrafenib Mesilate Powder (タフィンラー小児用分散錠１０ｍｇ)](https://www.nifujipharma.com/drugs/4291046X1027) — １０ｍｇ１錠, Novartis Pharma